Quest Pharmatech Stock Investor Sentiment

QPTFF Stock  USD 0.01  0.00  0.00%   
Roughly 56% of Quest PharmaTech's investor base is looking to short. The analysis of overall sentiment of trading Quest PharmaTech pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Quest PharmaTech's historical and current headlines, can help investors time the market. In addition, many technical investors use Quest PharmaTech stock news signals to limit their universe of possible portfolio assets.
Quest PharmaTech pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Quest daily returns and investor perception about the current price of Quest PharmaTech as well as its diversification or hedging effects on your existing portfolios.
  
over two months ago at news.google.com         
Quest PharmaTech Announces Results from AGM - GlobeNewswire
Google News at Macroaxis
over three months ago at news.google.com         
Allspring Global Investments Holdings LLC Has 5.50 Million Position in REV Group, Inc. - Defense Wor...
Google News at Macroaxis
over six months ago at news.google.com         
Quest PharmaTech Sets New 1-Year Low at 0.02 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Closing Bell Quest Pharmatech Inc flat on Monday - Barchart
Google News at Macroaxis
over six months ago at news.google.com         
Quest PharmaTech Restates Finances, Appoints New Director - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Closing Bell Quest Pharmatech Inc down on Thursday - The Globe and Mail
Google News at Macroaxis
over six months ago at news.google.com         
Heres Why Quest PharmaTech Must Use Its Cash Wisely - Yahoo Movies UK
Google News at Macroaxis
over six months ago at news.google.com         
Closing Bell Quest Pharmatech Inc up on Friday - The Globe and Mail
Google News at Macroaxis
over six months ago at news.google.com         
Closing Bell Quest Pharmatech Inc flat on Tuesday - The Globe and Mail
Google News at Macroaxis
over six months ago at news.google.com         
Closing Bell Quest Pharmatech Inc flat on Tuesday - Barchart
Google News at Macroaxis
over a year ago at news.google.com         
Neway, Quest Diagnostics partner for ESRD testing services - Medical Device Network
Google News at Macroaxis
over a year ago at news.google.com         
Photodynamic Therapy Market to Amplify Substantially by 2029- Brandessence Market Research - Benzing...
Google News at Macroaxis
over a year ago at news.google.com         
Oil and gas company CrownRock considers sale of business - Offshore Technology
Google News at Macroaxis
over a year ago at news.google.com         
Quest Diagnostics AAV test receives breakthrough designation - Medical Device Network
Google News at Macroaxis
over a year ago at news.google.com         
Global Benign Prostatic Hypertrophy Drugs Market 2023-2027 Combination Drugs Garner Rising Interest ...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Quest PharmaTech that are available to investors today. That information is available publicly through Quest media outlets and privately through word of mouth or via Quest internal channels. However, regardless of the origin, that massive amount of Quest data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Quest PharmaTech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Quest PharmaTech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Quest PharmaTech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Quest PharmaTech alpha.

Quest PharmaTech Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Quest Pink Sheet analysis

When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments